Track topics on Twitter Track topics that are important to you
NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Vicken Karageozian, MD, president of Allegro Ophthalmics, updates the phase 2 study progress for Luminate for the treatment of diabetic macular edema and the advancement to phase 3 trials.
Original Article: VIDEO: Allegro updates phase 2 studies on Luminate for DMENEXT ARTICLE
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...